Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|July 15, 2014
[Autonomic neuropathy--a problem of the circulatory system and digestive tract]Jari Punkkinen, Jari Koskenpato, Milla Rosengård-Bärlund
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
Help from habit reversal for supragastric belchingJari Punkkinen, Riikka Haak, Meri Kaartinen, et al.
Scandinavian Journal of Gastroenterology|April 13, 2026
Can the indications for gastroscopy in dyspeptic patients be tightened?Iida Ollila, Lauri Puustinen, Erika Tykkä, et al.
Digestive Diseases and Sciences|March 15, 2006
Measuring gastric emptying: comparison of 13C-octanoic acid breath test and scintigraphyJari Punkkinen, Ilmari Konkka, Olli Punkkinen, et al.
Neurogastroenterology and Motility|May 15, 2021
Behavioral therapy is superior to follow-up without intervention in patients with supragastric belching-A randomized studyJari Punkkinen, Meri Nyyssönen, Markku Walamies, et al.
Alimentary Pharmacology & Therapeutics|April 29, 2020
Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndromePerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Scandinavian Journal of Gastroenterology|December 29, 2023
Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data studyPauliina Molander, Mikko Kosunen, Heli Eronen, et al.
Inflammatory Bowel Diseases|May 7, 2014
Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remissionPauliina Molander, Martti Färkkilä, Kimmo Salminen, et al.
Journal of Crohn'S & Colitis|July 24, 2014
Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?Pauliina Molander, Martti Färkkilä, Ari Ristimäki, et al.
Pageof 2